Ikarian Capital, LLC - 30 Nov 2025 SCHEDULE 13G Report for Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
Symbol: QNRX
Shares outstanding: 839,437 shares
Disclosed Ownership: 211,538 shares
Ownership: 25%
Form type: SCHEDULE 13G
Filing time: 15 Dec 2025, 21:53:07 UTC
Date of event: 30 Nov 2025
Next filing: 06 Feb 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	25%	211,538	0	211,538	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	25%	211,538	0	211,538	/s/ Neil Shahrestani	Neil Shahrestani